These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Virus neutralizing antibodies at different stages of the HIV disease: increased levels after azidothymidine treatment. Schmidtmayerová H, Lackovicová M, Stanková M, Brůcková M, Surový I, Ujhelyi E, Füst G, Mayer V. Acta Virol; 1992 Mar; 36(2):157-65. PubMed ID: 1359767 [Abstract] [Full Text] [Related]
3. IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages. Ljunggren K, Broliden PA, Morfeldt-Månson L, Jondal M, Wahren B. Clin Exp Immunol; 1988 Sep; 73(3):343-7. PubMed ID: 3208446 [Abstract] [Full Text] [Related]
4. Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG. Janoff EN, Hardy WD, Smith PD, Wahl SM. J Immunol; 1991 Oct 01; 147(7):2130-5. PubMed ID: 1918947 [Abstract] [Full Text] [Related]
6. Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine. Hamkar R, Jalilvand S, Mokhtari-Azad T, Nouri Jelyani K, Dahi-Far H, Soleimanjahi H, Nategh R. J Virol Methods; 2005 Dec 01; 130(1-2):59-65. PubMed ID: 16026863 [Abstract] [Full Text] [Related]
7. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I. Böttiger B, Ljunggren K, Karlsson A, Krohn K, Fenyö EM, Jondal M, Biberfeld G. Clin Exp Immunol; 1988 Sep 01; 73(3):339-42. PubMed ID: 3208445 [Abstract] [Full Text] [Related]
8. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women. Hamkar R, Jalilvand S, Abdolbaghi MH, Jelyani KN, Esteghamati A, Hagh-goo A, Mohktari-Azad T, Nategh R. East Mediterr Health J; 2009 Sep 01; 15(1):94-103. PubMed ID: 19469431 [Abstract] [Full Text] [Related]
13. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Thomas HI, Wilson S, O'Toole CM, Lister CM, Saeed AM, Watkins RP, Morgan-Capner P. Clin Exp Immunol; 1996 Feb 01; 103(2):185-91. PubMed ID: 8565298 [Abstract] [Full Text] [Related]
14. Prevalence of rubella antibodies among schoolgirls in Sana'a, Republic of Yemen. Sallam TA, Raja'a YA, Benbrake MS, Al-Shaibani KS, Al-Hababi AA. East Mediterr Health J; 2003 Feb 01; 9(1-2):148-51. PubMed ID: 15562744 [Abstract] [Full Text] [Related]
15. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers. Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF. Clin Immunol; 2001 Feb 01; 98(2):212-9. PubMed ID: 11161977 [Abstract] [Full Text] [Related]
16. Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients. Aidoo M, Nishiwaki O, Akari H, Brandful JA, Ampofo W, Hayami M, Ayisi NK. West Afr J Med; 1994 Feb 01; 13(3):150-1. PubMed ID: 7841103 [Abstract] [Full Text] [Related]